News & Events

Testing Commences in Christie Hospital

Stokes Bio commenced testing at the Christie Hospital, Manchester, U.K. on the 19th November. The initial experiments are focused on bio-marker detection for soft and solid tumours using the 384X Stokes Bio instrument.

Successful Experiments in NUI Galway

Stokes Bio appoints a new CEO

Dr Jim Walsh joined as CEO in February 2007. He is a Chief Operations Officer of Trinity Biotech and having some 25 years of commercial diagnostic experience.

Stokes Bio appoints Paul Wyatt

Paul joins Stokes after 14 years of experience with ABI in the US followed by four years as VP of Fluidigm.

Stokes Bio first qualitative PCR results

Stokes Bio demonstrates its first qualitative PCR results from both its droplet based and isothermal systems showing good comparisons for same amplification from standard platforms.